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Breast cancer is acknowledged in the United States as a phenomenon. With more than 3 million 
women either diagnosed or treated for it as of 2019, it is a seminal part of the American 
healthcare map. However, the market for the kinds of bras and bandages patients have to wear 
after surgery remains mostly overlooked and outdated. This thesis aims to explore what it means 
to bandage or dress a breast that has been altered either in combative or cosmetic procedures. 
Why post-surgical wound care for breasts still mostly looks like a sports bra? How do breast 
cancer patients rehabilitate and reconcile their bodies, when society expects women to look 
“whole” and “sexy”? How is gender inequality woven into the interaction between doctors, 
insurance providers, and patients? Are post-surgical bras a medicalized item? Through an 
amalgamation of market research with a literature review, this thesis considers the world of post-
surgical bras as a social and medical continuum. Within this continuum emerges EZbra, a new 
fem tech product created by a breast cancer patient. Since EZbra was created to fill a void in the 
market, its very existence is commentary on the market itself. Therefore, in addition to 
evaluations of EZbra the product through different theoretical strains, the analysis likewise 
incorporates interviews with the company heads. Is EZbra itself merely symptomatic of the 
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CHAPTER 1: INTRODUCTION 
I would like to start this introduction chapter with a scenario I believe many would 
recognize: one morning, a woman stands under the shower spray and suddenly feels a lump in 
her breast that was not there before. She tries to palpate it, her mind racing. Do I have breast 
cancer? Is that how it starts? She tries to think back on all those self-exam diagrams she’s seen 
on the internet. Is it warm? Is her skin pebbled? What should she do? She steps out of the shower 
in a state of panic. Maybe she has a loved one. She asks them to feel up her breast. What do they 
think? She searches for tips on what to do. She eventually goes to see a doctor, gets sent to a 
mammogram, and later, a biopsy. It comes back positive. It’s early, but it’s cancer. If she has 
insurance or some sort of health coverage, the conversation veers very quickly toward surgery.  
A BCS or a mastectomy, and maybe some sort of continuing treatment. It’s so fast. She barely 
has time to even digest that she has cancer before she sees the results on her body. She does 
whatever the surgeon says to do, buys what he tells her to buy. She asks around for advice on 
what to do for the first few days after. There’s no stopping this now. 
This hypothetical woman perhaps doesn’t apprehend several things have happened to her 
body: by being diagnosed with breast cancer, she has entered a kind of continuum in the medical 
system in which she is now forever marked as diseased. She has undergone a process of 
biomedicalized objectification in which her body is now a site for combative and cosmetic 
procedures. She has unwittingly joined a sisterhood infiltrated by rogue charities and corporate 
powers seeking to make money off her misery. She is now under additional social scrutiny: is 
that a wig because of chemotherapy? Did she get implants? Are those her eyebrows? Did she 
gain weight from her treatment? If she lost weight, does that mean she’s worse? All of these are 
new conversations in her life that she did not consent to, nor willed to be part of. But it’s the 
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reality of breast cancer in the United States in the 21st century. 
Breast Dressing is primarily about the kinds of wrappings placed around the breast area 
for breast cancer patients. It’s about bandages and bras, about wound compression and holding 
drains, about scars and newly molded breasts. It’s also about a system in which women are 
beholden to additional rules and regulations on the way their breasts should be covered or shown. 
It’s about a medical world in which the majority of patients are women and the majority of 
doctors are men. It’s about gatekeeping in form of nurses, hospital buyers, and health insurance 
providers. And it’s about a niche market that nonetheless serves millions of women in the US 
alone. Academically, it’s about the writings of mostly female scholars who were either deeply 
affected by their own diagnoses, or chose to write about other women’s. It’s about feminist, 
queer, and dis/ability theorists trying to mold the field of philosophy, so male-driven, into their 
own worldviews. Consequently, it’s about power struggle. 
In the process of acquainting yourself with this thesis, you will first read about the market 
for post-surgical bras and bandages. You will be given the statistics I managed to gain access to 
and speculation about what I could not. You will learn about how and when breast cancer 
patients have their breast areas bandaged for them and what they do in the preliminary period 
following their surgery. You will learn about some of these patients’ new lives. Then, you will 
read a more theoretical analysis on how post-surgical bras function as fashion items, and whether 
they should be considered to be medicalized items. Finally, you will be introduced to EZbra, an 
Israeli company currently marketing a new surgical-grade product which combines a bra and a 
bandage. You will see how this product works within a system that has never seen one of its kind 
before, and how it could potentially revolutionize treatment for breast cancer patients both 
medically and emotionally. 
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How did I get to write and research about this topic? In the summer of 2016, I flew to Tel 
Aviv to sit shiva for my maternal grandmother. Among many of the extraordinary women who 
came to console our family, two in particular stood out for me. Efrat Roman and Yael Gibor, 
founders of EZbra, told us about their experiences with breast cancer so eloquently. My mother, 
who knew about their company, made a passing joke about an eventual case study at Harvard 
Business School. I remember thinking to myself, I don’t want Harvard to do this case study. I 
want to do it. This idea changed the course of my academic life. 
In the process of working on my thesis, every professor, colleague, or friend who 
discussed it with me had the exact same reaction: “it’s a very grim subject, isn’t it?” and always 
in the same sort of tone, that could you not come up with a different topic tone. Women 
constantly, unconsciously covered their chests when I discussed my research with them. My own 
mother initially could not understand it, she was the one who introduced me to EZbra’s women. 
In truth, breast cancer doesn’t occur in my family. We have no genetic history of it, and we 
luckily never experienced a diagnosis either way. But that doesn’t mean breast cancer doesn’t 
surround our lives. I see it everywhere.  
I saw it in the voice teacher I had in high school who never confessed her diagnosis to 
me, even when I saw her in a wig and no eyebrows. I saw it in the 28-year old wife of a friend 
who ended up with a tattooed incision scar. I saw it in the mother of a childhood friend who died 
of a metastasized reoccurrence, leading her daughter to eventually undertake a preventative 
double mastectomy. I read it in the New York Times one morning, when Angelina Jolie decided 
to come forth with her own fears and trauma. I heard about it from a woman I met in dance class, 
who voiced her struggles. Breast cancer is a topic that seems grim only to people who still see it 
as a distant fear. Those who unfortunately experienced it as a viable threat were open and honest 
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with me, when I told them of my intended research. 
By reading this thesis, I hope you will gain better understanding of the post-surgical bra 
world, which is underrepresented in academic research. I hope you will understand how vital it is 
to research what is happening in the post-surgical market, because breast cancer patients feel its 
effects deeply. I hope you will understand how granular the world of post-surgical bras can get, 
compared to the outside forces influencing it. I also hope you will learn about the extraordinary 
history of breast cancer advocacy in the US, and its current implications. I hope you will 
understand that, as prominent a cause breast cancer is, patients have varied experiences of it 
partly due to this prominence. Finally, I hope that any breast cancer patient reading this thesis 
will feel that she is seen and heard. As someone who grew up in a country with universal 
healthcare, I firmly believe that patient rights are of utmost importance in the current condition 
of the American healthcare system. I stand by their side. 
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CHAPTER 2: UNDERSTANDING POST-SURGICAL BRAS AND BANDAGES 
The World of Breast Cancer: Terms, Procedures, and Aesthetics 
This chapter offers a primer on the main themes in Breast Dressing, as they pertain to 
breast cancer and its culture: breast cancer definitions and procedures, breast reconstructive 
surgery categories, post-surgical bras and bandages, and breast prostheses. This will hopefully 
illuminate the relationship between breast cancer patients and their treatments, the product 
market, and how feminist and sociological theories factor in the discussion. This introduction 
would also be valuable to understand the innovation EZbra offers in the chapter on the company. 
The information in this chapter stems from scholarly work, discussions with plastic surgeons and 
breast cancer patients, and research of online shopping hubs both general and specific to breast 
cancer culture. 
Breast Cancer: Diagnoses, Procedures, Further Treatment 
While breast cancer treatments are widely publicized, this part of the introductory 
glossary will offer explanations for all breast cancer-related procedures. The use of post-surgical 
bras and bandages is present at every stage of breast cancer, from diagnosis to remission. 
Therefore, it is important to explicate when and how they operate. 
According to the American Cancer Society (or ACS), there are four types of breast 
cancer in existence: luminal A, triple negative, luminal B, and HER2-enriched. There’s also an 
early diagnosis (also called “in situ” or “stage 0”) of breast cancer, where a benign tumor that has 
yet to spread (or invade) into nearby tissue is discovered. The ACS estimates that in 2019, more 
than 268,000 cases of invasive breast cancer will have been diagnosed in women and more than 
2,600 in men. The mortality rate of breast cancer is roughly 42,000 women and 500 men a year. 
It should be mentioned that the mortality rate of breast cancer has been in steady decline since 
 13 
the 1990s. As of 2016, there have been 3.5 million women living with a history of breast cancer 
in the US, either in treatment or in remission. 
Generally speaking, the two leading ethnicities of women diagnosed with breast cancer in 
the United States are Caucasian and Non-Hispanic Black women. While statistics show near-
equal numbers of patients, Non-Hispanic Black women are likelier to be diagnosed with triple 
negative breast cancer (which does not respond to anti-hormonal therapy), at a younger age (their 
median age is 59 as compared to Caucasian women’s 62), and with the highest mortality rate 
(due to a myriad of factors, one of which is widespread racist attitudes in the medical community 
toward them). Breast cancer also has a genetic component, the importance of which has been 
widely researched and applied to diagnostic tools. Women who have had a close family member 
(a mother or a sister) with breast cancer diagnosis are at a significantly higher risk for breast 
cancer themselves, regardless of the presence of the BRCA genes.  
Diagnostic Methods 
 
The most widespread initial diagnostic tool for breast cancer is manual check. This can 
be done by the woman suspecting she might be ill, or by a person she trusts to touch her (whether 
it’s a loved one or a medical professional). Thorough manual checks are performed with no 
clothes on, as some of the symptoms of breast cancer can be seen or felt in the skin. 
If a breast cancer diagnosis is suspected, the woman can undergo a mammography. In 
this procedure, the breast is flattened by an x-ray machine in order to be able to get a clear view 
of any tumors. Women in menopause are encouraged to have an annual mammography, as 
they’re at a higher risk of a diagnosis. Mammography, however, is a controversial method of 
diagnosis, as it is commonly reported to be either a very uncomfortable or actually painful 
method of detection. 
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The most invasive (but most accurate) form of verifying a breast cancer diagnosis is by 
biopsy of the suspected tumor. Analysis of an extracted sample of tissue or fluid can show 
whether the tumor is malignant or benign. There are three types of biopsy procedures that can be 
performed in this case (two by needle, one by surgery), depending on which kind of sample is 
wanted. Biopsies can be performed either under local or general anesthesia (as in the case of 
surgical biopsy).  
Breast Cancer Prognoses 
If the breast tumor biopsy shows cancerous cells, the following steps depend on three 
things: what kind of breast cancer is diagnosed, how large is the tumor, and whether it has spread 
to the lymph nodes and other organs. The course of treatment is decided depending on the 
severity of the diagnosis and the type of cancer found. There are several combinations of 
treatment methods, ranging from BCS (breast conservation surgery), mastectomy, chemotherapy, 
radiation therapy, and anti-hormonal therapy. The majority of early and mid-stage (I-III) breast 
cancer patients undergo a combative surgical procedure, followed by radiation and/or 
chemotherapy. Late-stage (IV) breast cancer patients often forego a surgical intervention and 
undergo a combination of radiation and chemotherapy. 
Combative Procedures for Breast Cancer 
The two most common surgical methods of surgical intervention for breast cancer 
patients are breast-conservation (lumpectomy or partial mastectomy) and full mastectomy 
procedures. Breast-conservation surgeries (BCS) only entail removal of the tumor itself and any 
affected tissues. This may or may not include removal of the nipple as well. BCS is most 
common during Stage I/II diagnoses, as the tumor is yet to invade the lymph nodes and nearby 
organs. However, both in BCS and in mastectomies, there is the possibility of removing the 
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lymph nodes.  
In the case of a full mastectomy, the breast tissue is entirely removed. This rarely ever 
includes the muscle tissue under the breast nowadays (also known as a radical mastectomy), as 
breast cancer seldom invades that area. However, surgical procedures such as these are subject to 
the agreement of the patient, and many patients who are eligible for BCS still choose to undergo 
a mastectomy instead (ACS). Mastectomy can be performed on one or both breasts, depending 
on the spread of the cancerous cells. In addition, many women (and most famously, Angelina 
Joliei) who test positive for the BRCA genes and have a history of breast cancer in close family 
members opt to undergo preventative double mastectomies to eliminate any future occurrence of 
the disease. There is a lot of debate in the medical community whether this is necessary. As one 
can see, the psychological weight of combating this diagnosis weighs heavily in surgical 
consultations, and even more so for reconstructive surgery. 
Post-Surgical Treatment 
 In the majority of breast cancer diagnoses, surgery is not the end of combative treatment 
against the spread of the disease. Any combination of radiation, chemotherapy, and anti-
hormonal therapy can be used to further reduce the spread of cells, depending on the type of 
cancer and what stage it is in. Many women undergo one or more cycles of combative therapy in 
order to completely stop the spread through aggressive courses of treatment, all of which have 
debilitating side effects, some permanent. The timeline of any of these therapies can stretch from 
weeks to years (as is in the case of anti-hormonal therapy, which can go up to 5 years after 
surgery).  
Understanding Breast Reconstructive Surgery 
Historically speaking, Breast reconstruction is a procedure that essentially goes hand-in-
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hand with the modernized version of mastectomy procedures. The earliest account of breast 
reconstruction dates back to 1895 with a surgeon by the name of Vincent Czerny, who tried an 
early method of autoplasty to cover post-mastectomy breast defects. The name of the patient he 
operated on is unknown (Woodman 73). The inception of breast reconstructive surgery lies in 
attempts to combine early versions of breast augmentation procedures in plastic surgery with the 
medical community’s attempts to mend the bodies of patients who have undergone the Halstead 
mastectomy (the leading combative procedure at the time). Though it is related to breast 
augmentation, reconstructive surgery doesn’t answer a need for bigger or higher breasts, as it 
works with an area that has been incised. In its current manifestation, reconstructive surgery is 
divided into two major categories: autoplastic and alloplastic. Generally speaking, more than 
100,000 reconstructive procedures are performed in the US every year (American Society of 
Plastic Surgeons). 
Autoplastic reconstructive surgery refers to a type of procedure in which the surgeon uses 
the patient’s own healthy tissue to construct a new breast or reshape an existing breast. When 
shaping a new breast, the surgeon normally relocates fatty tissue from the stomach area into the 
breast area. The tissue is then shaped into a breast that is symmetrical to the patient’s other 
breast. This procedure is, in fact, a double procedure: by relocating fatty tissue from the stomach, 
the surgeon essentially performs a “tummy tuck” (abdominoplasty) in addition to breast 
reconstruction. The newly shaped breast has the advantage of feeling similar to the removed 
breast, as it is warm to the touch. In the case of reconstructive surgery for BCS, the surgeon 
rearranges the existing breast into a shape that does not look incised.  
The current leading autoplastic reconstructive procedure performed is the DIEP Flap. In 
this procedure, the plastic surgeon only uses fatty tissue to construct a new breast for the patient 
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right after the mastectomy. This is a procedure that has better success rates than the previous 
leading procedure technique: the TRAM Flapii. In the TRAM Flap, the plastic surgeon used both 
fatty tissue and part of the abdominal muscle from the patient to construct a new breast. This 
procedure was considered hard to recuperate from, as it was essentially as traumatic for the 
patient’s body as the mastectomy. In comparison, the DIEP Flap is easier to recover from, 
though it too is longer than recovery from alloplastic procedures. 
Alloplastic reconstructive surgery is a procedure in which the incised breast is replaced 
with an implant. Though it sounds more old-fashioned than autoplasty, alloplastic surgery has 
developed much in the past decade. For breast cancer patients who do not have to undergo 
radiation therapy, it offers immediate, full reconstruction, much like autoplastic surgery. While 
in the past this was usually divided into two separate procedures, nowadays, they occur during 
the same procedure: after the oncological surgeon finishes the mastectomy, the plastic surgeon 
steps in and immediately reconstructs a new breast using an implant and the patient’s own skin. 
While the implant is harder and colder to the touch than live tissue, an alloplastic procedure 
offers a shorter and easier recovery process for the patient.  
There are, of course, exceptions to these procedures. For example, women who have to 
undergo radiation therapy after their mastectomy cannot undergo immediate reconstructive 
alloplastic surgery. In these types of cases, the procedure would be divided into a mastectomy 
and delayed reconstruction. However, there is a second option in alloplastic surgery which 
potentially alleviates the feeling of loss: during the mastectomy, the surgeon inserts an 
“expander” form under the muscle, which can then be periodically inflated using saline shots. In 
theory, this allows the skin to slowly stretch into a new breast shape with temporary fluid. Once 
the radiation therapy is over, the expander is taken out during alloplastic surgery and a 
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permanent implant is inserted instead into the area. While this is a longer process, it eventually 
allows for a shorter recovery overall.  
Understanding post-surgical bras and bandages 
 
What do the terms “post-surgical bras” and “post-surgical bandages” mean? As the topic 
of Breast Dressing, post-surgical bras should be clarified to those who might not be acquainted 
with them. Both post-surgical bras and post-surgical bandages refer to different points in 
women’s recovery from all mammoplasty procedures. They have multiple uses and are an 
indispensable part of the recovery process. In the case of breast cancer, their meanings 
compound.  
“Post-surgical bras” refers to two different types of bras used in recovery and remission 
phases for breast cancer patients. One type is an actual bra used for bandaging after the surgery is 
performed (either BCS or mastectomy). The surgeon places the post-surgical bra on the patient 
while she’s still under general anesthesia in the operating room. This bra is soft, with no 
underwire, and fastens at the front (fig. 1). Its purpose is 
mainly to cover the incision line and hold any drains at 
the lymphatic area (armpits) if they are placed. In some 
cases, this bra is given to the patient by the hospital. In 
other cases, the patient purchases it either with or without 
the surgeon’s recommendation. As designs of post-
surgical bras of this kind have been largely borrowed from sports bras, they offer a greater 
degree of compression than t-shirt or push-up bras, for example. However, these bras are not 
without problems: because of the design, they also rely on shoulder straps, which is a problem 
for post-mastectomy breast cancer patients. When the breast is incised into, the skin and probable 
Figure 1. Post-Surgical Bras with front closure. 
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parts of the pectoral muscle are damaged, making it nearly impossible to lift one’s arms 
unassisted. This problem is compounded when the lymph nodes are also removed, damaging 
lateral and shoulder muscles. 
The levels of compression required from post-surgical bras of this kind vary according to 
surgery type. In the case of a BCS or a full mastectomy with no reconstruction, compression is 
very important, as it prevents infection. The bra serves as part of the wound treatment, and it also 
holds the drains in place. However, if immediate reconstruction is performed, especially 
autoplastic reconstruction, the bra should not compress the breast at all. In this case, the purpose 
of the bra is to only cover the wound. It should especially not have any pressure on the underside 
of the breast, as that’s the location of the incision line. 
The second type of post-surgical bras is intended for women who eschew reconstructive 
surgery either temporarily or permanently. In lieu of a breast implant 
or molded breast, the bra offers room for a prosthetic insert of a breast 
shape in order to create the illusion of symmetry and wholeness (fig. 
2). There are also prosthetic inserts available for women who undergo 
BCS. The prosthetic inserts vary according to material type and 
occasion, and they are offered in a range of standardized sizes, skin 
tones, and activity style. For instance, there are different types of  
prosthetic inserts and bras for patients who engage in cardiovascular activity or swimming. 
Inserts can be placed in bras or glued to the patient’s chest with an adhesive. Prosthetic inserts in 
standardized sizes cost between $100-$300 an insert, 
and they are not commonly covered by health 
insurance. Additionally, there are also prosthetic 
Figure 3. Examples of prosthetic 
inserts. 
Figure 2. Examples of nipple prostheses. 
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nipples for prosthetic inserts that don’t feature a nipple design. They have a wide range of prices 
according to material, adhesive, and make (fig. 3). Women who undergo reconstructive surgery 
also tend to opt for prosthetic nipples, as mastectomies often cannot conserve the skin around the 
breast, including the nipples. 
In breast cancer culture lingo, the kind of post-surgical bras that can hold a prosthetic 
insert are referred to as “pocket bras,” meaning the 
pocket where the prosthetic insert goes into (fig. 4). 
Other than those pockets, however, the bras have a 
similar aesthetic range to bras on the more conservative 
side of the mainstream market, and they fit all kinds of 
activities and occasions. Several leading brands of 
“pocket bras” place a great emphasis on the desirability 
of the design. Many of the bra designs contain lace and satin-like materials. 
“Post-surgical bandages” is a term referring to the surgical-grade bandage placed directly 
on the incision line of the women operated on.  The 
SilversteinWrap (fig. 5) is an example of a post-surgical 
bandage aimed specifically at women who undergo 
mammoplasty procedures, particularly breast cancer-
oriented ones. Bandages are most often used in all kinds of 
procedures: breast biopsies, radiation therapy, non-
reconstructive BCS or mastectomy, and immediate reconstruction using a chest expander. In 
most of those cases, the bandage is first placed on the woman during surgery, then redressed by a 
medical professional, whether it’s a surgeon or a breast cancer nurse. It is essentially wound 
Figure 4. Examples of "Pocket Bras." 
Figure 5. The SilversteinWrap. 
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dressing, and it is temporary.  
Conclusion 
This chapter serves to help the reader better understand the world in which breast cancer 
breast dressings operate. Women who have been diagnosed with breast cancer often have to buy 
several types of these dressings during the course of their treatment. In the conversations I have 
had with patients, many confessed to discarding their used post-surgical bras once they did not 
need them, even if there were a chance they would be needed again in the future. This places 
breast dressings not quite at the same level as regular bras, as those are intended for long-term 
use. The psychological component of breast dressings is also significant, as they make the 
trauma of the surgery either increased or decreased according to levels of comfort and aesthetic 
satisfaction.  
In the following chapters, all of the breast dressings described here would be debated in 
several different ways: first, they will be investigated as borderline products between the fashion 
world and the medical world. This will include considering them as an example of 
medicalization, such as it is defined in the medical sociology world. Other theory strains, such as 
Foucauldian, Butlerian, and dis/ability, will shed a different light on breast dressings as both a 
symbol and a step in the normalization process for breast cancer patients. They will also show 
how breast cancer in general has been pushed into the public health agenda, and how it contends 
with the extensive fetishization of breasts in Western society. Finally, the product created by 
EZbra will show how breast dressings can further improve in design and usage to help breast 
cancer patients recover. This will include personal interviews with the people involved in the 
making of the product and company, as well as others in the breast dressing world. Hopefully, 
this examination of breast dressings will deepen the understand of their dichotomous existence as 
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intimate recovery aids and symbols of objectification and self-worth.  
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CHAPTER 3: POST SURGICAL-BRAS AND BANDAGES – BETWEEN FASHION AND 
MEDICINE 
Introduction 
Of all the cancers in existence, nowadays, breast cancer is the most well-publicized. 
Consequently, breast cancer-related causes have raised the most amount of money. In 2011, Lea 
Goldman wrote for Marie Claire that breast cancer causes (medical or social) raise in the 
upwards of six billion dollars annually. Goldman then investigated how fashion houses try to 
boost sales and publicity by marketing pink clothes and accessories every October (Breast 
Cancer Awareness Month) in the US. This is certainly well-trodden ground. Pink ribbon culture 
is a corporate, well-oiled money machine, as Gayle Sulik marked in Pink Ribbon Blues. While its 
seeming target is to raise awareness and publicly support breast cancer patients, not much good 
comes out of it in reality. And, most notably, the post-surgical bra market rarely sees any new 
developments from it.  
Post-surgical bras are not products often thought about by the general public. For this 
reason, it’s important to consider them in relation to the women who wear them. It is also 
important to consider how and why post-surgical bras function as a fashion item and a medical 
item, both in theory and in practice. Therefore, in this chapter, I attempt to trace the history of the 
two general types of post-surgical bras and how they are connected to the fashion industry. I then 
link their existence to feminist theory, the rise of the Women’s Health Organization in national 
discourse, and finally how dis/ability theory relates them to medicalization. Foucauldian theory 
is used extensively in order to understand how notions of bio-power and discipline shape female 
breast cancers patients’ lives, as they purchase post-surgical bras for medical treatment, 
recovery, and general lifestyle.  
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Post-Surgical Bras in the Fashion Sphere 
In order to trace the timeline of post-surgical bras, a division 
should be made between the bras intended for wound dressing and bras 
with prosthetic inserts. According to Erin Pappas in Cultural 
Encyclopedia of the Breast, the origins of the wound dressing bras can 
be directly traced to the first designs of sports bras in the 1970s by Lisa 
Lindhal and Hinda Miller (fig. 6). Both were graduate students who 
enjoyed running, but wanted a bra that would greatly reduce the bounce 
of their breasts. Their initial design entailed two jockstraps sewn 
together, ironically enough, and part of it still lives in “racerback” sports bras (227). This idea of 
semi-comfortable compression translated into post-surgical bras, just in softer fabrics and no 
underwires. Post-surgical bras with prosthetic inserts (“pocket bras”) can be traced back to the 
first “breast kits” from Reach to Recovery, though the first prosthetic breast design dates back to 
the 1880s. 
Like much of what we consider to be disposable fashion, lingerie is a market that relies 
on wear-and-tear and is therefore in constant growth (Statista.com). Within the lingerie market, 
however, the growth of bra sales hinges on several components: they are often more expensive 
on average, bring up questions of correct size and fit, and require their users to own different 
kinds for different clothes’ shapes and occasions. While bras are arguably made of more durable 
material than, say, underwear, they also are more prone to losing their elasticity and subsequent 
function. After all, if a bra can’t hold up the breasts it encapsulates, it’s not a good bra. While 
there are ongoing discussions on how a bra is supposed to fit and how it’s supposed to work, the 
Figure 6. The original 
"Jockstrap Bra." 
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market nonetheless has standardized size ranges both in band and cup, as well as specific shapes 
and designs (t-shirt bra, pushup bra, etc.).  
As mentioned earlier, post-surgical bras are either a step during rehabilitation for the 
wearer, or provide ongoing support to the wearer for the rest of her life. This is the case with 
post-mastectomy patients who opt for wearing a prosthetic insert in their bras. The medical 
benefits of post-surgical bras lie not only in wound compression (as long as the bra is the correct 
choice for the patient), but also offer drain support and aid in preventing dermatological side 
effects (such as lymphedema). In the case of breast cancer patients who choose breast 
reconstruction, the post-surgical bra helps keeping the shape of the new breast a certain way in 
order to expedite the healing process. This, however, is what they ideally do.  
The reality of the post-surgical bra market is more complicated, and often involves cases 
in which the healing process is regressed rather than progressed. As Samantha Crompvoets found 
in her research on bras with prosthetic inserts, the benefits of wearing them are far from what the 
advertisements or doctors claim: women who use them described a life full of discomfort 
coupled with fear of wardrobe malfunctions, and unforeseen problems with product 
maintenance. A lot of the problems account for the prosthetic inserts themselves, rather than the 
bras. This is potentially true for other types of post-surgical bras. That being said, post-surgical 
bras with prosthetic inserts are still considered the better option than a post-surgical chest binder 
(Laura et al.). 
Post-Surgical Bras and the Rise of Women’s Rights 
The question of aesthetics concerning post-surgical bras is important for a very simple 
reason: it’s a product that, in theory, provides physical and mental aid to its wearers. It tackles 
issues at the heart of the feminine bodily experience within patriarchal society and the internal 
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misogyny it promotes: what happens when the “whole” feminine body is disrupted, particularly 
in the breast area? As women’s breasts are so widely fetishized in mainstream American culture, 
the disrupted female body was hidden in shame for a long time. This disruption was brought into 
light by The Women’s Health Movement (WHO) and Second-Wave feminist scholars in their 
own separate ways.  
Starting in the late 1950s, WHO activists took to confronting the medical establishment 
on its injurious treatment of breast cancer patients. They promoted the right of women to choose 
their treatment courses, including the types of surgery they should undergo. They successfully 
fought for the modification of the Halstead radical mastectomy into procedures that were not as 
needlessly mutilating (such as a modified mastectomy or BCS). They also created Reach for 
Recovery, a widespread volunteer organization intent on aiding breast cancer patients in their 
initial recovery from surgery. Its role lay in disseminating knowledge, giving a moral boost, and 
supplying a small kit which included a lamb’s wool form to imitate the look of the lost breast in 
a bra (Lerner). 
Post-Surgical Bras within Pink Ribbon Culture 
Samantha Crompvoets discusses how society inscribes femininity as one where the 
female body must have two healthy breasts, and how heavy this psychological weight is on 
female breast cancer patients. Though her research focused on how the marketing of breast 
prostheses uses this kind of bodily inscription, it is important to note that post-surgical bras are 
part of the process: the return to everyday routine, including wearing a bra, is considered normal. 
This particular kind of normality is also a social construct that heavily leans on what American 
sociologists have called “pink ribbon culture.” 
  In the book Pink Ribbon Blues, Gayle Sulik tackles pink ribbon culture: the American 
 27 
mainstream culture of women who have been diagnosed with breast cancer. As a disease that 
mostly attacks women (90% of the patients), breast cancer was promoted to the public agenda in 
the 1970s and only became more visible since. It is a disease that attacks women at one of their 
most vulnerable areas, and not because breasts are more important organs than others: breasts, as 
perceived in American culture, are a Western aesthetic construct, and they are directly related to 
what the public considers to be the “worth” of a woman. To the general Western public, a 
woman who possesses a diseased or mutilated breast is a lesser woman. It is a concept so 
pervasive in the aesthetic ideals seen every day in mainstream media, even women who do not 
have breast cancer modify their breasts in order to fit those ideals. The situation is many times 
harder for breast cancer patients. 
 In her discussion of pink ribbon culture, Sulik echoes sentiments most famously 
described by Barbra Ehrenreich in her Harper’s Magazine essay, “Welcome to Cancerland.” 
Ehrenreich and Sulik discuss this culture as both insular and corporate. Breast cancer is the most 
profitable type of cancer for health service providers, and therefore insidiously attractive to 
health insurance providers. It also has the inauspicious combination of being a highly publicized 
private disease: it attacks women in huge numbers, meaning “everyone knows someone,” but it 
also attacks women in a way that causes them to feel even more insecure. This is partially why a 
beauty market exists solely for the purpose of helping ill women perform health. Society cheers 
those women on their “fight” while simultaneously shames them for their consequent 
appearance.  
Post-Surgical Bras within Critical Theory and Feminist Theory 
 
In order to understand what it means to have a diseased breast and why so many women 
seek to hide them from the public with prosthetic inserts and special mastectomy bras, this 
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chapter will turn to feminist and dis/ability theory for explication. Practically all theoretical 
constructs discussed in this part are based on the social theories of Michel Foucault. Because of 
this, there are varying interpretations of his work. As Foucault discussed the invasive and 
damning influence of social institutions on people in the public and private spheres, his theories 
can be elucidated in different ways according to each philosophical stream. However, all of the 
following interpretations are legitimate in their connection to the post-surgical bra market, 
particularly the prosthetic-insert “pocket bra” market, which is singularly discussed in here. 
The most broadly known feminist interpretation of Foucault’s work in our time comes 
from Judith Butler. In her works on gender performativity/citationality and embodiment, Butler 
deconstructs what society conceives as gender and the body. Both, she theorizes, are not natural 
concepts and have never been so, are constructs created by public institutions in order to govern 
people. Society learns how to perform gender in order to fit in, trying to fulfill the criteria set for 
what is considered to be an ideal body. In other words, anyone who challenges those criteria, 
whether they are not part of the gender binary, are not heterosexual, are not Caucasian, or are not 
able-bodied, is ostracized and eventually punished. Butler concerns herself with the materiality 
of human existence because human bodies are governed material. 
The notion of materiality is a concept Zillah Eisenstein raised in her own partial 
autobiography on her life as a breast cancer patient, Manmade Breast Cancers (2001). As an 
Ashkenazi Jewish woman with a family history of breast and ovarian cancers, Eisenstein tries to 
balance breast cancer within the private and the public spheres of the disease. In the public 
sphere, she is part of a group historically marginalized by medical research at large and 
specifically when it comes to breast cancer. In the private sphere, she is a woman who tries to 
reconcile the manifold identities of herself in her own body as it goes through the ups and downs 
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of health and illness:  
“My breast cancer body does not say enough about how other body demands have choreographed 
my life. Although breast cancer has often suffocated me and I have felt like there is almost no air to 
breathe, my body has had other selves. I am never simply my cancer because I have other bodies 
and I am something besides my body struggles. But meanings and discourses continually invade 
this process of knowing anything. I make myself think that I am never just my body, and yet I 
know my body can consume and destroy me” (42). 
Eisenstein’s frankness in her writing on the tension between the hardiness and 
vulnerability of women’s bodies and the attempt to theorize it within known (male-created) 
philosophies is a theme that echoes in many famous “mammographies” (breast cancer-themed 
autobiographies). The most well-known of these in the genre are Audre Lorde’s powerful self-
chronicles The Cancer Journals and A Burst of Light. In these two volumes, Lorde describes her 
struggles both with her (ultimately terminal) diagnosis and the medical establishment’s treatment 
of breast cancer patients. Most famously, Lorde denounces in The Cancer Journals opting for 
breast reconstruction and breast prostheses, writing that “[to] imply to a woman that yes, she can 
be the ‘same’ as before surgery, with the skillful application of a little puff of lambs-wool and/or 
silicone gel, is to place an emphasis upon prosthesis which encourages her not to deal with 
herself as physically and emotionally real, even though altered and traumatized” (56-57). 
Though some feminist theorists consider Lorde’s opinions on prosthetics and 
reconstruction to be emblematic of modernist sovereign models (Ehlers 123-124), it nevertheless 
remains that Lorde’s writing advocated strongly not only for breast cancer patients, but 
especially for the bodily experiences of Women of Color with the disease. Lorde vocalized the 
difficulties of living with breast cancer in a culture that still seeks to quiet and shame ill women, 
where doctors and nurses still overwhelmingly mistreat Black womeniii. Her writing aided in 
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building momentum towards the Women’s Health and Breast Cancer Rights Act of 1998, six 
years after she passed away (DeShazer 40-41). Lorde, then, had significant influence on the 
public discourse in the way breast cancer is seen, not only as a disruptor of women’s lives, but 
also as a disruptor of socially acceptable bodies. 
The politics of materiality in women’s bodies, especially those with breast cancer, call 
into question the notions of norms and normality. As Nadine Ehlers writes, Audre Lorde’s 
journals depict norms as a “top-down manner” of forcing a set of constructs on peoples’ bodies. 
However, Ehlers then complicates Lorde’s views as she conflates them with Michel Foucault and 
Judith Butler’s writings on norms as “regulatory ideals” through which “bodies come into being” 
(124). In other words, Butler’s Foucauldian writings on bodies describe embodiment as a way for 
people to construct themselves, rather than being made to construct by institutional power. This 
is especially evident in Butler’s writing on “doing gender.” 
Gender performativity (or, as Butler later called it, citationality), is the concept of human 
behavior that reproduces gender that agrees with societal norms. When women feel as if they 
have to present themselves as feminine, they reproduce femaleness as a gender. Tied to this 
gender are notions of a certain kind of attractiveness and softness that appeals to heterosexual 
men educated to perceive only that kind of femaleness as desirable. As this is the most common 
form of female performativity promoted in Western society, it’s no wonder why women feel 
compelled to perform it at all times. This kind of performance also has to do with the 
psychological comfort breast cancer patients feel when they opt for additional surgery beyond 
the one intended to save their lives. There is nevertheless an even more sinister side to this 
particular phenomenon. 
Breast cancer-related surgeries often result in a pair of misshapen breasts, or even a 
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situation in which one breast has been removed, creating the possible need for either 
reconstruction or prosthetic inserts. In her paper on the medicalization of women’s breasts, 
Magdalena Wieczorkowska specifically explains breast cancer surgical procedures and their 
consequences as a phenomenon that could be interpreted through Michel Foucault’s theories of 
bio-power: by raising national awareness for breast cancer as a leading, preventable cause of 
death for women, political and medical institutions categorize it as a danger to society. As a 
result, women diagnosed with breast cancer are defined, as Wieczorkowska writes, as “an object 
of biopolitical decisions and medical interventions,” unlike healthy women seeking plastic 
surgery procedures (165). By this, she means that BCS and mastectomies are government-
endorsed procedures which alter the female patient’s body with the intention to cure her cancer 
and transform her back into a healthy citizen.  
Wieczorkowska also points out that the lack of recognition for breast cancer patients’ 
physical and emotional needs directly clashes with Western society’s concepts of aesthetic ideals 
(168). Female breast cancer patients first experience the medicalization of their breasts by 
institutional power (which robs them of their conditioned self-image). They are then made to 
conform to socio-aesthetic ideals after undergoing debilitating and deforming medical 
procedures by either hiding the results or seeking plastic surgery. Any additional surgery on the 
area could potentially further damage their self-image and bodies. There are also racial 
disparities between women who choose to undergo breast reconstructive surgery in either form, 
with Black women choosing to do so in significantly lower numbers than white, Asian, or Latina 
women (PlasticSurgery.org).  
The invention of the post-surgical bra, therefore, is unsurprising and at least partially 
reactionary to these conflicts. With it, patients attempt to reconcile the medicalized and 
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fragmented female body, the commercial-aesthetic concept of the fragmented female body (as 
Wieczorkowska writes in her analysis), and above all, the reunification of the fragmented body 
parts into a whole. Women exist as both fragmented and whole-bodied in current society, as 
aesthetic expectations tend to fragment their bodies into parts in need of “improvement” (i.e. de-
aging or emulating an idealized view of the body part). With post-surgical bras, they re-
assimilate their breasts, condemned as diseased by medical professionals, into general society 
and its consequent expectations. 
Post-Surgical Bras and the Question of Medicalization 
 
Because of the tight and sometimes-overlapping relationship post-surgical bras of all 
types have with medical treatments (wound dressing) and with fashion items (aesthetic dressing), 
one should consider what its relationship could be with the process of Western medicalization. 
This term was made famous by sociologist Peter Conrad (though he did not invent it), 
medicalization according to him means “a process by which nonmedical problems become 
defined and treated as medical problems, usually in terms of illness and disorders” (DasGupta 
120). While medicalization has a widespread application to all manner of fields, with breast 
cancer, it remains close to dis/ability theory: breast cancer is considered to be a disability, and 
like other disabled people, breast cancer patients are forced to hide their bodily experiences from 
the general public. 
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As dis/ability theorist Rosemarie Garland-Thompson wrote in her 2002 essay on visual 
rhetoric of disability in popular photography, the mastectomy scar was a forbidden image of 
disabled women for virtually the entirety of the 20th century. It continued to be taboo as women’s 
breasts became widely eroticized in popular photography, from fashion, to celebrity, to 
pornography. Garland-Thompson focuses in her essay on the campaign of the Breast Cancer 
Fund titled “Obsessed with Breasts” in the year 2000, in which women bearing mastectomy scars 
starred in parodies of a Calvin Klein ad, a Cosmopolitan cover, and a Victoria’s Secret catalog 
(70). She discusses how this particular campaign marries up eroticized breasts with the 
medicalized breast, causing to “advance a potent feminist challenge not only to sexism in 
medical research and the treatment for breast cancer but also to the oppressive representational 
practices that make erotic spectacles of women’s breasts an everyday thing while erasing the fact 
of the amputation that one women in eight 
will have” (72).  
In addition to Garland-Thompson’s 
commentary, it should be mentioned that in 
the entire campaign, the women photographed 
are white, thin, and conventionally attractive. 
This is intentional, of course, as the women 
who were commonly featured on all three 
origins of the examples were white. However, it allows an unexpected window into the kinds of 
visuals that are considered to be acceptable even among breast cancer patients. As white women 
continue to be featured not only in promotion of the disease, they also feature in most of the 
modeling pictures for post-surgical bras and bandages (fig. 7).  
Figure 7. examples of models for post-surgical bras 
from Google Shopping. 
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In 2001, Garland-Thompson wrote in a treatise on feminist dis/ability studies how 
medicalization intersects with aesthetics and breast cancer (12-14). She first links the 
Foucauldian concept of “discipline” to cosmetic procedures of all kinds. When Foucault wrote 
about “discipline” in relation to women, she argues, he theorized a translation of extreme social 
pressure to answer standardized social criteria with invasive medical procedures. Women both 
elect to change their bodies (cosmetic and reconstructive surgery) and have their bodies changed 
without having elected to do so (forced sterilization and the Halstead radical mastectomy) in 
order to fulfil these criteria. In challenging those norms or constructs, feminist theory intersects 
with dis/ability theory, as they both promote the notion of an unstandardized, non-normalized 
female body. 
The meeting of medicalization with breast cancer and aesthetic procedures has to do with 
standardization. Female breast cancer patients use reconstructive surgery to seek to “correct” a 
body in order to make it acceptable according to public norms (Ehlers). This makes the area of 
the mastectomy or BCS a place where mental and physical recovery is medicalized into 
procedure. After all, breast cancer patients are not legally forced into reconstructive proceduresiv, 
or even “pocket bras:” like Audre Lorde, many choose to keep the breast loss visible and 
unchanged. However, social norms dictate that women should have two whole, symmetrical 
breasts. This means that by choosing to undergo additional procedures to have two whole 
breasts, an aesthetic regulation becomes a medical issue. In other words, reconstructive surgery 
is there to “fix” what has been rendered “ugly” by previous surgery. Medicalization is simply 
another symptom in what Foucault defined as social “discipline,” in which men dictate, dissect, 
and decorate women’s bodies according to the rules they originally set. 
How does the medicalization discourse relate to post-surgical bras? For Garland-
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Thompson, they fall under the same category as reconstructive and other aesthetic procedures, 
because they too are part of the attempt to “correct” disabled women’s bodies. The prosthesis is 
central to dis/ability theory for many reasons, and for feminist dis/ability theory, breast 
prostheses are a focal point. Not only do they not aid in motor function, Samantha Crompvoets 
found, they in fact hinder daily movement. Women who use “pocket bras” need to purchase 
different bras and prostheses for different activities, depending on the intensity of their 
movement and level of undress. Women who swim, for example, need a different prosthesis than 
women who do yoga. Women who wear low-cut tops need a prosthesis that might fit a strapless 
bra. This may seem out of the realm of medicalized products, but it’s not: returning to an active 
lifestyle is considered imperative for physical recovery from breast cancer, and retaining a sense 
of self is imperative for psychological recovery. Women who use “pocket bras” essentially adopt 
them as part of their holistic identity in order to move on from the trauma of surgery and other 
treatments. This, arguably, means that post-surgical bras are medicalized items as a whole, 
because they are an under-discussed aspect of breast cancer treatment for the women who wear 
them.  
Concluding Remarks 
Reconciling the two different worlds in which post-surgical bras exist is only doable if 
the aesthetic criteria women have to answer to daily is taken seriously. These criteria are so 
pervasive in the lives of breast cancer patients, either “pocket bras” or reconstructive surgery 
become an aesthetic imperative. “Pocket bras” continue to do steady sales, and reconstructive 
surgery has risen in popularity. While the American Society of Plastic Surgeons has released a 
statistics report, which points toward a decline of 3% in reconstructive surgery in 2017, it 
nevertheless rose a dramatic 35% since the year 2000. Considering this in light of the Audre 
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Lorde’s writing, for instance, it becomes clear that a certain type of breast cancer patient 
construct has taken ahold of women. While reconstructive surgery doubtlessly took leaps and 
bounds in technique and results since Lorde’s time, it also enshrined itself as part of a plastic 
surgery reality. Breast augmentation, in this reality, is still the most popular aesthetic procedure 
in the US. With more than 300,000 breast augmentation procedures performed in 2017 alone, the 
visibility of augmented breasts in society makes reconstructive surgery a generally accepted 
decision to make, and it is covered by health insurances and Medicare.  
This artificially enhanced materiality of women’s bodies also connects to the notion of 
“pocket bras” as an aesthetic norm. Because post-surgical bras relate to the social construct of 
women both as fashionable items and medicalized items, they are part of breast cancer patients’ 
process of embodiment: they contribute to the feeling of wearing a bra, a normalized process in 
many women’s lives; they might aid in helping some of the patients’ own reclamation of their 
libido by feeling sexually attractive, especially when the bra design is aimed at that; and they 
function as part of what is known as “recovery wear,” a subset of fashion aimed at how breast 
cancer patients present themselves either during or after treatment. In this way, post-surgical bras 
are a technology aimed at enhancing embodiment. This embodiment, as iterated previously, can 
be seen in positive and negative ways simultaneously.  
At its core, feminist theory is certainly antagonistic towards the notion of internalized 
heteropatriarchal aesthetic ideals in any person, especially if the person is suffering from an 
illness. And yet, it seems several feminist theorists have adopted a pragmatic approach to 
artificially enhanced embodiment, especially posthuman feminists following the footsteps of 
Donna Haraway’s famed “Cyborg Manifesto.” Many women don’t consider the replacement of 
an amputated breast with a prosthesis or an implant to be dictated on them. The psychological 
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process of deciding whether to reconstruct or not is incredibly complex. I would even argue that 
fully challenging these aesthetic ideals would be a lost battle. However, medical innovation to 




CHAPTER 4: EZBRA – GROUNDBREAKING INNOVATION OR SYMPTOMATIC 
SOLUTION? 
Introduction 
This chapter of Breast Dressing examines the company EZbra, the product it is now 
starting to sell, and the people behind it. Through the story behind the company and its product, 
this chapter will also examine the following themes: how 
products made for and by women with breast cancer 
challenge not only the male gaze-fueled current market for 
breast cancer patients, but also the ways in which medicine is 
still methodized and distributed by men. EZbra’s 
headquarters are based in Israel, but it is in the process of 
opening an office in New York City as it starts to penetrate 
the American market for wound dressing. EZbra has also embarked on a marketing campaign 
aimed at American breast cancer patients either at prognosis stage or in treatment. Founded in 
2014, it is still a new company in funding stage, though the product itself is already being sold 
online and presented in medical conferences. 
 As mentioned in the introduction chapter, I became acquainted with the women behind 
the company in 2016, and kept in regular contact with them ever since. Once my research got 
approved, I was able to officially interview them and EZBra’s chief medical consultant, Dr. Eyal 
Gur. They kindly answered all of my questions and elaborated on ideas and experiences they 
have had with breast cancer in treatment, as well as a medical market. This chapter, therefore, 
attempts to analyze how EZbra as a product navigates the tough, outdated market of post-
surgical bras and bandages, the effect it will have on breast cancer patients, and the changes it 
Figure 8. EZbra Phase  1. 
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could bring to the medical world at large.  
EZbra – The Company 
The history of EZbra as a product and company starts with the breast cancer diagnosis of 
CEO and patent originator Efrat Roman. During her tough years of treatment and recovery, she 
came up with the initial concept for the design. After doing a patent search and not finding 
anything, Roman registered a partial patent for the product in 2011. However, she could not 
finish it without the process of submitting a full design, something she had no training in. This is 
when Yael Gibor came into the picture. 
CTO Yael Gibor heard of Roman in 2012 when she was doing research for her final 
project at the Holon Institute of Technology (HIT). As her project had to do with breast cancer 
patients dealing with breast asymmetry (the result of combative procedures), one of the patients 
she interviewed conveyed to her Roman’s plans. Even so, Gibor only contacted Roman when a 
colleague from her program sent her a link to a talk Roman gave on her life and work. The 
connection between Roman and Gibor was immediate: both were already separately in the 
process of developing some kind of product to alleviate unforeseen needs for breast cancer 
patients. Together, they advanced EZbra from a half-planned patent to a full product that is now  
transitioning into mass production on an international scale (fig. 8).  
EZbra – The Product 
Designing and preparing EZbra for manufacturing was mainly the work of Yael Gibor. 
The design had different prototype stages (conceptual, initial models, raw material-sourced 
models), and it took several years to reach what is now called “phase 1” of the company (fig. 
9&10). When I asked her about the process, her answer was illuminating:  
“The idea of a breast dressing – Efrat came up with it already. The way we decided to turn it into 
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a product was something that took 6 months, from the initial idea I had in my mind for the whole 
project. But to bring it to life, to add the raw materials to it, to source them, to finalize those 
features took between a year to two years. And then, to bring it to production and the FDA 
[approval] took another two years.” 
Though Gibor had already worked on bra design with 
a local factory in Israel for her final HIT project, she 
had to learn firsthand how to develop an entirely new 
bandage design into manufacturing. This included 
sourcing medical-grade raw material, finding the 
correct technique to manufacture the design, and then 
find a factory with the correct machines to do so. 
Gibor also described the difficulties in finding companies willing to work with EZbra on a small 
scale with the understanding that eventually the product would go into mass production:  
“We needed to find companies that understand our dreams, are visionaries and can look ahead and 
see the potential of the product, and know that today they sell us low quantities of product but in 
the future, we will grow and use them … to find a contractor that can manufacture EZbra. It’s some 
kind of a square, 10x10 dressing, and it’s not a hygiene product that can be flexible with the sizes 
and everything (like adult diapers for example). We needed to have it manufactured under medical 
supervision. It was very tricky to find a factory that can really take this product and achieve what 
we needed.” 
When I spoke to Efrat Roman on the inception of EZbra as a product, she articulated her 
disbelief on the lack of similar products in the market:  
“I thought that because [I was treated] in Israel … there are no good solutions. I was sure that in the 
modern, more advanced world there would be some kind of a disposable bra which is [also] a 
dressing. It was clear to me that I couldn’t be the only one who thought about that.”  
Figure 9. EZbra development illustrations courtesy of Yael Gibor. 
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When a patent search yielded no results, Roman did her own preliminary design. However, it 
was Gibor who came up with the final prototype of Phase 1 EZbra: a surgical-grade bandage 
with no adhesives that wraps around the chest, easily fastens at the front, is capable of holding 
drains as needed, and is customizable to each breast separately.  
Roman believes the product is applicable to all 
breast-related procedures: “eventually, EZbra will have to 
become the standard of care wherever there’s a breast 
procedure, and that means cosmetic, plastic, breast cancer-
related, radiation, biopsies, everywhere.” This means that 
the market for EZbra is far wider than just breast cancer: 
women having their breasts augmented, and even 
transgender folk wishing to either reduce or enhance their breast area could use it after surgery. 
I’ve been given to understand that Phase 2 of EZbra consists of more availability of patterns and 
extended sizes. The company is also likely to expand its marketing campaigns. 
EZbra in the Current Market for Breast Cancer 
In the previous chapters of this thesis, I have discussed the current market for both wound 
care and post-treatment care for breast cancer patients. Breast dressings are a constant in the lives 
of breast cancer patients from prognosis to remission, as every procedure requires dressing 
afterward. Additionally, these dressings are often either ill-fitted for the procedure, or are made 
from materials that cause further damage to the patient’s skin. This is something both Efrat 
Roman and Yael Gibor had in mind while designing and manufacturing EZbra. Roman in 
particular was adamant on not using any surgical glue-like materials in the product, as she 
experienced an allergic reaction to the adhesive in bandages placed on her: 
Figure 10. EZbra conceptual design courtesy of 
Yael Gibor. 
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“after [the surgeon and nurses] realized that my skin was [reacting] really badly to the adhesive, 
they took out the other [tape] as well. By the way, the adhesives left a lot of scars on my skin. This 
is something that I kept on hearing from other patients as well: that the surgeons would make their 
best effort that the scar [from the incision] was going to be beautiful because this is where their 
prestige is. But then, the wound care leaves horrible scars on the sensitive skin of the breast.”  
Herein lies a lot of the irony when it comes to wound dressing products in the American market: 
while surgeons take utmost care not to leave extensive scarring in the incision area, the dressings 
themselves are harmful to the patients and undo the surgeons’ work.  
Roman mentioned in the interview that she was eventually bandaged with gauze and 
ACE bandages, which is apparently a common wound dressing strategy for breast cancer patients 
in the US. However, bandaging the chest area with ACE bandages is a dangerous practice that 
has long been advised against. This is especially true in the transgender community, where ACE 
bandages are considered an inexpensive form of chest binding. In a study conducted by 
researchers at Johns Hopkins and Boston University in 2016, the usage of elastic bandages such 
as ACE bandages for the purpose of breast compression was commonly associated with negative 
health outcomes, “a finding consistent with existing community recommendations against their 
use” (73). There are many connections to be had between transgender men and non-binary folk 
who regularly utilize binding methods, and breast cancer patients who seek similar types of 
compression. Using ACE bandages for compression is a practice that should be questioned in 
wound dressing for breast cancer patients. The lack of obvious overlap between the two 
communities in medical and social research is suspect as well. 
In the post-surgical bra and bandage primer chapter, the two leading wound dressing 
methods in the breast cancer world are either thick bandages or mastectomy bras. There are 
problems with both of these methods: due to their thickness, the bandages are very visible under 
clothing. Mastectomy bras, on the other hand, have straps and therefore require either tough arm 
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maneuvers, or help from another person while putting them on and taking them off, as arm 
mobility is hindered after combative breast cancer procedures. Furthermore, there is problem for 
both that has to with hygiene: some surgeons do not want the patient to change dressing until the 
incision is fully healed. Others are fine with changing dressings according to need. In both cases, 
the patient either has to stay with a gradually dirtier dressing (as there is seepage and bleeding 
from the incisions), or wash a gradually dirtier and more stained bra. EZbra takes the bandage 
route in here, as it is one-time use, but it is still dependent on the post-surgical course of 
treatment dictated by the surgeon. It is still a better solution than a sports bra, on the other hand, 
as it does not have straps and compression can be controlled for each breast separately. 
 Another product in the post-surgical market EZbra might be up against is the popular 
Brobe: Allison Schickel’s post-surgical robe with pockets for drains and a detachable bra. The 
design is made with the patient’s comfort, treatment, and aesthetic trauma in mind, and it is 
estimated to make $1.2M annually. The Brobe is also a new company, and like EZbra, it is still 
in the process of raising money for the purpose of expansion. The advantage of the Brobe bra on 
EZbra is also potentially its disadvantage: the bra and the robe go together. On one hand, 
according to the Brobe testimonials, it is extremely comfortable to wear and lends itself to 
treatment and recovery after a combative procedure. On the other hand, the lack of versatility in 
the clothes makes EZbra an option for women who might opt for street clothes. As journalist 
Lisa Miller writes in her op-ed for New York Magazine on her breast cancer struggles:  
“ If maternitywear is an indignity to style-conscious women, then mastectomywear is far, far 
worse, and within that realm the Brobe reigns supreme … If you have a mastectomy, you need 
some way to support and manage those tubes, and the manufacturers of the Brobe and its imitators 
have capitalized on this. Anticipating my mastectomy, I might not have known what to wear, but I 
knew it wasn’t a freaking Brobe.” 
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EZbra could also be considered through the lens of “pocket bras,” as they traditionally have 
been used to ease the trauma of a mastectomy or BCS. As Maren Klawiter describes in her book, 
Biopolitics of Breast Cancer : Changing Cultures of Disease and Activism, part of the intense 
process of biomedicalization breast cancer has undergone in the early 20th century is gifting the 
postop patient a “breast form.” Hospitalized women in recovery were given half-bandage, half-
bra dressings with place for the “breast form,” often made of lamb’s wool. The goal was to ease 
the ordeal that was the Halstead radical mastectomy both on a short-term and long-term scale. 
On a short-term scale, this is what EZbra essentially is for: a dressing that is comfortable and 
eases both psychological and physical burdens of breast cancer treatment, albeit in an opposite 
way: instead of hiding away the missing breast, EZbra endeavors to accommodate it. In doing so, 
it crosses a barrier in the history of breast cancer and aesthetics in 20th century America. 
EZbra and Aesthetics 
It is difficult to discuss the ways in which EZbra could be a groundbreaking product 
without considering the history of breast cancer aesthetics in the United States. As previously 
mentioned, Maren Klawiter narrates exactly this phenomenon in her book, especially when it 
comes to the creation of the “closet:” the socially oppressive regime under which mainly white, 
middle-to-upper-class potential breast cancer patients were highly encouraged to seek medical 
help, but then discouraged to talk about its devastating implications. Women who did not belong 
to this particular socio-economic group fared even worse (and still do). American breast cancer 
culture functioned for the majority of the 20th century under this regime, in the vast shadow of 
the Halstead radical mastectomy.  
Klawiter often codeswitches between hetero-feminist and queer-feminist theories when 
she examines the social aspects of the “closet,” starting with using the term “closet,” now 
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synonymous with hiding one’s sexual orientation or gender identity. Upon discharge from the 
hospital, breast cancer patients were told to “go back to normal life” and “act as if nothing has 
happened” (75), hiding their extensive physical and emotional scarring from everyone in their 
lives. Thus, they were fully “closeted” about their distress and attempted to “pass” as “normal 
women.” The act of “passing” (another loaned term from queer and intersectional theory) is 
highly performative and taps into social stereotypes in the extreme: the need to look healthy, the 
longing to appear whole, and the yearning to feel desired all come with a strict set of rules which 
are nearly impossible for women to achieve at best. 
EZbra debuts as a product in the US during a time of great aesthetic and medical turmoil: 
as women opt for reconstructive surgery in decreasing numbers, the number of cosmetic 
mammoplasty procedures is skyrocketing. At the same time, the market for “pocket bras” 
remains viable, yet distinctly veiled in its revenue: not a single company creating breast inserts or 
mastectomy bras has ever gone public. Several, in fact, have been purchased by other 
companiesv. Therefore, it is difficult to accord for the state of the current market for any non-
medical-grade post-surgical bra. As a product, EZbra competes with post-surgical bras as they’re 
used for bandaging, but the issue of aesthetics in a heteronormative society remains a real 
problem. 
What does it mean for breast cancer patients to feel attractive or desired? During my 
interview with Dr. Eyal Gur (EZbra’s chief medical consultant), the issue of physical comfort 
versus psychological comfort in post-surgical bras came up:  
“One of the women whom I’ve suggested to try EZbra had some issues putting it on the right way 
in the beginning, but she said, ‘it is not sexy. I wanted to look sexy after surgery.’ A black bra was 
maybe not comfortable, but at least it was sexier than [a] white cloth or bandage.”  
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Gur talked about his patients almost exclusively in terms of heterosexual lifestyles, which wasn’t 
a surprise: non-heterosexual women are considered a minority among breast cancer patientsvi, 
and they seem to opt for reconstructive surgery in smaller numbers than heterosexual patients do. 
In the case of Gur’s work, the patients were mostly Israeli. However, the issue of 
heterofemininity within American breast cancer patients is dominant as well, and could be an 
issue EZbra would be facing.  
Another facet of aesthetics in post-surgical bras and bandages has to do with dignity. 
Preserving a patient’s dignity while they receive treatment is a paramount concept in the medical 
community, specifically in the nursing community. When it comes to diseases with social stigma 
like breast cancer, the importance of dignity increases exponentially. Because of the way breasts 
are fetishized in Western society, breast cancer patients’ loss of bodily autonomy is even more 
traumatizing to them. This problem is exacerbated with the gender disparity between patients and 
surgeons, as most surgeons are male. Dignity is even a selling point for a few post-surgical 
brands and prototypes during and after surgery: it relates to the patient’s needs for comfort and 
discretion as they face initial recovery. 
The concept of dignity also depends on the patient’s ability to regain bodily autonomy as 
quickly and wholly as possible. Since patients receive their first bandaging during surgery, their 
ability to change bandages as needed is a significant step in maintaining dignity. Moreover, it 
conveys the way the patient wishes to display herself in public, whether it’s the way she looked 
prior to hospitalization or not. These kinds of deliberations are directly linked to performativity 
of health and illness, as well as deliberations of comfort and sexual desire. EZbra as a product 
could potentially quicken the regaining of dignity in patients, depending on how easily the 
patient can tie it and whether her oncological nurse is trained in using it. The longer it takes, the 
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less bodily autonomy it provides.  
EZbra and Critical Theory 
Michel Foucault’s theories on social control, particularly governmentality, have been 
consistently used to elucidate the different forces at play within the American breast cancer 
industry and community. Sonia Báez-Hernández certainly delves into Foucault’s theories as she 
propagates the dire situation of underrepresented communities within breast cancer discourse. 
However, when she elaborates on the corporeality of breast cancer treatment, Báez-Hernández 
turns to Erving Goffman’s concept of “identity kits.” Within this process of embodiment, women 
have to reconcile the physical attributes they possess being permanently or temporarily altered 
by surgeons and combative therapy. There’s an “interplay between memories and self-
monitoring mediated normality” that Báez-Hernández incorporates into those changing “identity 
kits,” which “has multiple purposes: 1) to control the body’s appearance and illness; 2) to avoid 
an uncomfortable situation; 3) to avoid pain and outbreaks of emotions; 4) to maintain one’s 
composure; and 5) to avoid causing oneself and others embarrassment” (146).   
In a previous chapter, I have argued that society fragments women’s bodies into pieces in 
need of “improvement.” This fragmentation is still more damaging to the bodies of breast cancer 
patients. Báez-Hernández similarly considers the bodily trauma breast cancer patients undergo to 
“have the power of fragmentation” (147). In this particular context, Goffman’s “identity kits” are 
disfigured by treatment to the point of “a disembodiment of reality.” How, then, can one product 
provide any kind of relief? That would depend on the cumulative effect of a well-chosen form of 
aid. In terms of materiality, Erving Goffman’s “identity kits” are both tactile things and routines. 
They are, in his words, the way in which a person “expects to exert some control over the guise 
in which he appears before others” (20) for the preservation of “physical integrity” (21). If EZbra 
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manages to assist breast cancer patients in developing a routine of healing from disfigurement, 
then it will have done its work as part of an “identity kit.” 
EZbra’s place in Feminist and Dis/Ability Theories 
The role of agency in feminism is paramount and present in every theory strain. With 
agency, women are able to self-liberate and self-actualize themselves not only out of difficult 
situations, but also to ameliorate their lives at large. The examples are ample: suffrage, the ability 
to own property and finances, access to education in all levels, marrying at will or not marrying 
at all, etc. In terms of embodiment and feminism, agency is crucial: reproductive rights, control 
over one’s appearance, eliminating false patriarchal narratives such as hysteria, etc. In breast 
cancer culture, agency has come to mean several things: first and foremost, the complete change 
breast cancer advocacy has brought not only to doctor-patient relations, but also to patients’ 
ability to choose their course of treatment. Additionally, it also has to do with the deterioration of 
the “closet” in many ways: it is now more acceptable than ever for patients to show signs of their 
course of therapy, whether it’s eschewing wigs or forgoing reconstruction and “pocket bras.”  
Lately, breast cancer patients’ agency has taken a different route. Instead of merely 
advocating for better treatment and social recognition, patients are now openly creating products 
to help others in their courses of treatment. While EZbra is the chosen example for the purpose 
of this thesis, there are several others: AnaOno, which makes lingerie for all stages of treatment 
or remission; LympheDIVA, which offers compression sleeves to protect from lymphedema in a 
great variety of colors and patterns; Pink Perfect, which provides custom-made realistic 
prosthetic nipples; and even The Shower Shirt, which allows patients to protect their incision 
area without forgoing basic hygiene routines.  
The amalgamation of agency, choice, and dignity is part of the feminist dis/ability 
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discourse in the world of breast cancer. It is a discourse that stands in the massive shadow of 
Audre Lorde’s Cancer Journals, and the all-encompassing effects it has had on breast cancer 
awareness. However, as Lorde’s writing is now 40 years removed from the reality of breast 
cancer, it is hard for current streams of feminism to account with its message of non-compliance 
with heterosexist norms. Several feminist scholars have since expressed difficulties living up to 
Lorde’s beliefs. In an essay on her choice to have autoplastic reconstruction, posthuman feminist 
scholar Diane Price Herndl discusses this very problem:  
“My choice to have reconstruction was to leap with both feet into the posthuman, the partial, and 
the contradictory. My new ‘breast’ reflects that: it is me to the extent that it is my own tissue, but it 
is alien because it has been moved, reshaped, and changed by technology. I am now partial, 
because a part of me is missing ... and because my choice reveals a partiality to normal appearance. 
[…]  Is my new ‘breast’ any less a visible sign of my interaction with technology than a 
mastectomy scar would be? To a certain extent, yes. It is certainly less visible to other people when 
I am wearing clothes. This invisibility of what happened to me is at the heart of Lorde’s resistance 
to prosthesis” (151).  
 The myriad of feminist interpretations of the diagnosed body touches on EZbra as well. As a 
versatile product, EZbra can be used for different processes of rehabilitation for patients, whether 
they choose to reconstruct or not. It most certainly falls under the definition of Feminist 
Technology (or “fem tech”), as Deborah G. Johnson describes in “Sorting Out the Question of 
Feminist Technology.” As an adjustable and customizable surgical-grade bandage specifically 
for different-sized breasts, EZbra is “good for women.” As a technology that treats the breast 
similarly to other organs to be correctly bandaged and compressed, it “constitutes gender-
equitable social relations.” As a product that answers a specific need for female breast cancer 
patients in their market, it “favors women.” Finally, as a design that could potentially supersede 
current faulty mastectomy bra designs, EZbra “constitutes social relations that are more equitable 
than those that were constituted by a prior technology or than those that prevail in the wider 
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society” (43). It is, in short, an equitable product under the rather inflexible terms of feminist 
theory. But is it truly helpful to women’s psyche, when all is said and done? 
EZbra and the Financial Predicaments in Current American Healthcare 
 As discussed earlier, the success of EZbra as a product seems to be predicated upon its 
cumulative use during recovery. Nevertheless, it operates in a system that is already biased 
against women as patients, consumers, and innovators. That it took more than a century of 
combative treatments for the conception of a specialized bandage alone is mystifying. Moreover, 
that EZbra has had trouble raising funds to start mass production when the market is clearly 
ready for it is even more enraging. That women are still expected to reuse mastectomy bras or 
ACE bandages on their incision site in a field controlled by men is galling. And that is not even 
the worst of their problems. 
How can breast cancer patients stay dauntless and continue to advocate for themselves, 
when their diagnosis is a harbinger for all kinds of complications? Setting aside the diagnosis 
itself and fast decision-making it forces women to do, breast cancer in the US is effectively a 
socio-economic tripwire. It forces women to contend with three immense issues which are 
potentially unsolvable: affording treatment, retaining a job, and maintaining respect from 
healthcare professionals. All three have deep associations with sexist and racist attitudes towards 
women in the US. Despite some improvement in the past four decades, they remain some of the 
leading causes behind early mortality and financial ruin for many breast cancer patients. 
Within this medical microcosmos, the cost of care for breast cancer patients is an 
enormous financial challenge. In 2018, a team of researchers from the University of Michigan 
found that nearly half of all breast cancer patients experience financial toxicity caused by their 
cancer diagnosis. The team additionally found that 45% of Black breast cancer patients, 36% of 
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all Latina patients, and 22% of all White and Asian patients experience food insecurity as a result 
of their diagnosis. Patients who are already below the poverty line are also more likely to abstain 
from doctor’s visits due to lack of health insurance, and are less likely to fully recover as a result. 
A breast cancer diagnosis also compounds the amount of debt patients with postsecondary 
degrees incur. With student debt in the US at an unprecedented high coupled with soaring health 
insurance premiums, patients are far likelier to sink further into poverty with a diagnosis. 
In light of the economic hardship many breast cancer patients endure, it may be 
challenging to view them as avid consumers, but as previous chapters have shown, consumers 
they are. This is due in part to the long treatment and recovery period patients experience, and in 
part due to the traumatic physical and psychological changes that occur in the process. The 
American breast cancer patient market is considered a niche market in comparison to common 
retailers such as Walmart, Amazon, and Apple, but it’s nevertheless significant. With more than 
3.5 million women diagnosed with breast cancer in the United States as of 2019, the market for 
breast dressings is large enough to merit growth in and of itself.  
In a conversation I’ve had with Dana Donofree, founder of AnaOno, a lingerie company 
for breast cancer patients, we discussed the market changes in the past decade. She opined that 
the internet altered the market by allowing patients access to more merchandise in extended 
sizes. At the same time, mastectomy stores, the point of access for many patients seeking health 
insurance coverage for their bras and breast forms, are slowly disappearing. Patients can acquire 
prescriptions for mastectomy bras, but prescriptions are not optional forms of payment in online 
purchases. This is the likeliest case with EZbra as well: even though it’s intended for immediate 
recovery and should be part of a hospital kit, it is highly likely that patients will have to purchase 
by themselves from EZbra’s website and other online retailers. 
 52 
When it comes to companies such as EZbra, finding willing investors is a massive hurdle. 
In research published as recently as 2019, Guzman and Kaperczyk have found that start-ups led 
by women in the US are much less likely to receive investments from venture capital funds. 
They also have additional difficulties in pitching their start-up ideas, as most managers in private 
equity and venture capital firms are men. As can be expected, start-ups for products aimed 
specifically for women by women with problems that are women-specific fall under the trickiest 
rubric for finding investors. Roman described it as one of the toughest obstacles still in EZbra’s 
way:  
“…When it came to raising funds, most of the financial assets are held by men. Trying to raise 
funds from men for a problem that only women are experiencing…it’s not something that has to do 
with pregnancy or the things that are easier to relate to as men. We came in and spoke about the 
terrible experience that women experience while facing breast cancer, which was scary to them. 
Speaking about women’s breasts not in a sexy manner, but in a painful and humiliating manner, 
made most of the men we spoke to very, very uncomfortable.” 
Donofree also mentioned the lack of male investors’ ability to both sympathize and reconcile 
business strategy with products that are not as universal either in the fashion or medical markets: 
“It’s hard to structure and sell your business in theory or an idea in a room full of people who don’t 
understand the needs of the consumers you’re aiming for. The harsh reality is that if they haven’t 
been affected by breast cancer, if their wives or daughters or sisters-in-law or best friends weren’t 
ill, it’s not their fault, they don’t understand…Business is also business. The harsh realities of 
making money, scaling, being an investable business…you have to find an investor who 
understands the revenues and type of business.” 
Breast cancer-oriented bras are presently penetrating mass market production, but not as 
independent companies. For instance, fashion label Stella McCartney and activewear label 
Athleta both launched mastectomy bra designs in 2019 (during Breast Cancer Awareness Month, 
of course), but those comprise a small part of a much larger collection. Smaller companies like 
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AnaOno and EZbra are competing with players even more powerful than the relative giants of 
the mastectomy bra market, Amoena and Anita Care, as Donofree explained: 
“The space is so much crowded now. Large companies are creating mastectomy bras because 
breast cancer is a hot topic, not because their bras actually work for people with breast cancer. It’s 
just another category for them. At least they’re taking notice. At least they see us.” 
The market, subsequently, has grown but somehow stayed very similar to the way it has been for 
the past several decades. Breast cancer patients have a real need for bras that aid their recovery at 
different stages, but even with the explosion of internet shopping, many products remain 
outdated or badly designed. In fact, some online shopping hubs are so outdated, many still 
feature models with natural breasts modeling mastectomy bras. This is a remarkably bad 
marketing strategy, as the cleavages and breast shapes of breast cancer patients are completely 
altered after surgery. Donofree described it as the “biggest insult” she faced when shopping for 
bras for her bilateral mastectomy, and in fact pushed her to create her own company in the first 
place.  
Likewise, in her essay, Diane Price Herndl discusses how hidden the breast cancer 
continuum can still be, despite its wide exposure. Herndl was explaining her painful autoplastic 
reconstruction in a beauty shop, when she noticed one of the saleswomen listening attentively. 
When she concluded her explanation, the saleswoman blatantly remarked that she would’ve 
loved to have it done herself, despite not having a cancer diagnosis. This comment might be 
shocking to some, but sadly, the breast cancer community is full of similar stories. The 
conflation of warped aesthetics with body fragmentation society forces on all women only 
increases with time.  
As plastic surgery has now become common, even reconstructive surgery is no longer 
considered an extraordinary choice to make even on healthy bodies:  “I thought that my voice 
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would outweigh the visible,” writes Herndl, “voicing of breast cancer, though, doesn’t 
always work” (152).  The visibility of breast cancer patients, therefore, remains 
extremely contentious in mainstream American culture. The process of normalization too 
is a double-edged sword: the less dire the choices breast cancer forces women to make, 
the more acceptable it is to talk about them. However, as medical procedures become 
normalized, less attention is given to women who are genuinely in need of medical 
intervention. Seen in this way, the recent arrival of EZbra doesn’t seem so unusual. Why 
would women need a bandage specifically for their breasts if reconstructive surgery is 
supposed to improve them? 
Conclusion 
After looking at EZbra from several different perspectives throughout this 
chapter, one could ask several questions about how it works and what it represents: is it 
truly a good product for breast cancer patients? What could we interpolate from EZbra as 
a company about the current state of healthcare in the United States? And finally, is 
EZbra truly a groundbreaking product, or is it merely a symptomatic solution for a 
deficiency in a broken system? That it merits these questions alone is testimony to the 
importance of this product in general. There are simply no other products like it as of 
2019, and the products it competes with do not offer the versatility it has. And yet, its 
very existence was not and still is not a sure bet.  
Is EZbra a good product for breast cancer patients? From the perspectives of 
feminist, critical, and dis/ability theories, it appears to be an excellent product. It allows 
for a range of treatments without having to account for any specific pre-surgical 
requirements, as is the case with other mastectomy bras. It can also be adjusted to the 
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post-surgical body according to need, whether it’s wound compression, drain location, or holding 
a breast shape. It does not leave the patient with the feeling of being constantly dirty. EZbra, 
however, does not look like a bra, and therefore may not answer for all the needs of a bra. To 
some patients, this is a genuine psychological drawback. Perhaps it can be viewed as a “step in 
the right direction” kind of product, which opens the door to other variations and iterations that 
would be able to cross this aesthetic obstacle. 
How can EZbra shed a light on the state of American healthcare, especially since the 
beginning of the 21st century? On one hand, it shows how damaged the healthcare system is, as it 
highlights what has been lacking in care and innovation for the quality of care and quality of life 
of breast cancer patients. On the other hand, it signifies a society changed by two major forces: 
the breast cancer advocacy movement, and the rise of the internet as a major player in 
representation and consumerism. As women increasingly use the internet as amplification for 
their needs and desires, their power is reflected more strongly in medical awareness, product 
innovation, and even medical research. EZbra is the product result of two women seeing a need 
in a world that did not conceive of it beforehand, yet many say is an absolute necessity. 
Is EZbra a genuinely innovative product that can revolutionize care, or merely 
symptomatic of a market behind the times? The answer is likely both: EZbra is the type of 
innovation that comes from a person’s experience, rather than a calculated gamble by corporate 
strategists and designers. It could potentially revolutionize the market for breast dressings in 
general by being both a comfortable bandage and a correct post-surgical solution. This kind of 
innovation, however, is symptomatic of its market and medical world at large. Breast cancer 
patients’ needs were simply not being met on a vast scale, and whatever products were used to 
inadequately assist them came from private companies with no real interest beyond a certain 
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price. 
The arrival of EZbra in the breast cancer market seems to be extremely good for 
the market, but its survival is still in question. With mixed patient reactions to the way it 
looks, it might have a problem truly penetrating the market. It also might have a problem 
with affordability due to its price for a one-time use product. Likewise, it might have a 
problem with gatekeeping: many nurses and surgeons are not aware of it yet, and 
therefore would be reluctant to use a product that would require them to learn a different 
bandaging technique. Consequently, when it comes to breast cancer, EZbra is essentially 
a stopgap product for a treatment process that entails trauma inflicted on women’s bodies. 
As Dana Donofree remarks:  
“I dream of the day when I go out of business because we’re no longer amputating breast tissue off 
of women’s bodies in order to save their lives. That is what we need. We need procedures and 
processes in which we no longer need to remove a body part in order to fight a disease.” 
The reality of EZbra is the reality of broadly prescribed organ amputation in 21st 
century American healthcare. It is also the reality of negligible health coverage and 
deficient government support on a massive scale. It is the reality in which women have 
need for agency and courage in face of a system that treats them while shaming them. It 
is the reality of a posthuman society in which dis/ability is visible and invisible 
simultaneously, while plastic surgery and cyborg fantasies spread and intensify in popular 
culture. In this reality somehow the private sphere exists, where women try to live day 
after day in their own bodies as they fracture and fragment. Offering them the proverbial 
bandage is equally ironic and pertinent, a tiny step in the direction of more equitable 
medical care. Only time will tell how effective EZbra can truly be to the patients who 
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need it the most, but it shows the lengths medical innovation can still go beyond pharmaceutical 




CHAPTER 5: CONCLUSION 
Breast Dressing marks the culmination of a long scholarly journey I have taken for the 
past three-and-a-half years. I did preliminary research on Gender Medicine, a theoretical lens 
that has become more popularized while I was writing about it. Once I understood the uneven 
playing field on which medicine aimed at women already stands, I focused my research on post-
surgical bras within the theoretical fields I have been studying. However, with every new article 
I discovered, there seemed have always been an accompanying personal story or history to what 
I was reading. Returning to the personal experience of women helped me simplify every 
academic examination of the writings of Foucault, Butler, Goffman, and Conrad. Once I dived 
into the different theoretical strains that have either directly discussed or related to the post-
surgical bra world, I returned to a more concise view of it. For this reason, I would like to share 
three personal anecdotes related to my thesis that happened just this past year. 
In May 2019, I participated in a departmental competition at the Graduate Center for best 
presentation of a thesis in miniature. I was two semesters into my final research at that point, and 
I had enough material to do the proverbial elevator pitch with confidence. When I mentioned the 
financial cost of owning “pocket bras,” there was an audible gasp in the room. It stays with me to 
this day. I think about all the graduate students in the audience: how they probably struggled to 
afford healthcare; how they had problems juggling school, work, and family; and how a breast 
cancer diagnosis could potentially terminate their fledging academic careers. And yet, they sat 
there, audibly gasping at what is considered to be a purely cosmetic purchase.  
The correlation between society, gender identity, aesthetics, and financial burden is well-
trodden ground. It’s why Reach for Recovery was started in the first place. It’s the reason breast 
forms were invented in the first place. The mindboggling notion that any woman would end up 
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not having two breasts and present her altered physique in public is still inconceivable to many. 
Breast forms are still sold everywhere, and many women still opt to use them instead of 
reconstructing. At the same time, the myriad variations of breast reconstruction still continue to 
evolve, from DIEP and TRAM flaps, to implants, to expanders, to nipple conserving, and so 
forth. Nonetheless, the financial cost to either reconstructing or not still plagues patients by the 
hundreds of thousands. 
The second anecdote has to do with a conversation I had just a few weeks ago with a 
woman I befriended during my time at the Graduate Center. We reconnected during a social 
event, and caught up with each other’s work. When I informed her of the topic of my thesis, she 
immediately replied, then you could help me! She was going to undergo a prophylactic bilateral 
mastectomy the following year. We discussed her treatment plan and the kinds of bras she was 
going to use. I privately wondered how many women needed this kind of conversation with 
someone in their lives.  
While the breast cancer community has certainly flourished online, lack of awareness and 
options for breast cancer patients remains an immediate problem for many women in the US. 
Recent research shows that one in four women is not aware she has the option to reconstruct, and 
that federal law requires health insurances or Medicare to cover the procedure (Breast 
Reconstruction Awareness Campaign). Additionally, many impoverished women have no access 
to affordable treatment, as Sonia Báez-Hernández discussed in her 2009 article. She herself only 
received adequate treatment once she managed to apply for a grant that allowed her access to a 
special hospital. Though Báez-Hernández was treated for breast cancer prior to the passing of the 
Affordable Care Act in 2010, constant attempts to strip the law remain an enormous obstacle for 
patients to afford treatment without going bankrupt. The 2015 Breast Cancer Patient Education 
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Act was aimed specifically at this, and yet, in 2019, it remains a problem. 
The third anecdote I wish to share relates to my first conversation with Dana Donofree. In 
October 2019, I was invited by Efrat Roman to attend a special EZbra event in Manhattan. The 
event was held in collaboration with the New York Breasties, a Facebook/Instagram group of 
women under 40 who were diagnosed with breast cancer. I found myself standing in a room 
filled with young career women who braved the stormy weather that day to attend the event. In 
the conversations I have had with several of them, I heard tales of stalled careers, debilitating 
procedures, and loss of self-esteem. While the atmosphere in the room was light, there was an 
undercurrent of anger, which only sharpened after Roman’s presentation of EZbra. How come 
this product only came by now? Why could these women not have had it when they were in 
treatment? Donofree in particular was incensed over the omnipresence of men in the way breast 
cancer patients were expected to look, whether it was plastic surgery or “pocket bra” companies. 
The stereotypical breast cancer patient has been an older woman for many decades, and 
as the average age of patients across all demographics remains post-menopausal, this is 
understandable. However, statistics show a marked increase in the number of younger women 
diagnosed. This is partly due to the widespread use of mammograms and education on self-
exams for likely symptoms. It is also due to environmental factors, such as the spread of 
carcinogen use in many industries. The number of breast cancer patients grows at a rate of 0.3% 
per year (ACS), and with it, medical innovation continues. At some point in the next few 
decades, it is likely that a blood test will be able to supplant most forms of early diagnosis. It is 
also likely that invasive surgical intervention will become a less common method of combating 
breast cancer.  
Breast Dressing marks a point in the timeline of the breast cancer continuum. It looks 
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into the past for explication and glimpses into the future for hope. It is an attempt to merge 
scholarship with real experiences of patients and medical professionals. It encapsulates a reality 
in which both academia and the post-surgical bra market struggle to keep up with the lives of 
women in a fractured healthcare system. At times, it was incredibly difficult to write, both 
emotionally and academically. It also leaves me with questions about the precarious prospects of 
my case study: is EZbra going to survive into the 2020s and beyond? I cannot say for sure. I 
sincerely hope it does, as it truly is a remarkable product, and its presence in the market will 
likely inspire other products of its kind. As it is, the breast dressing market continues to meander 
its way towards eventual obsolescence. It is nevertheless important to investigate, because lives 
continue to depend on its offerings. It is also my hope that a large-scale research on women’s 
quality of life using breast dressings is carried out. I believe it will prove vital for patient 
advocacy. Finally, I hope Breast Dressing was able to educate and interest, as it truly is a 











i Jolie wrote an op-ed in the New York Times, explaining her choice to undergo preventative 
double mastectomy with immediate reconstruction and an oophorectomy in the future, to spare 
herself the breast cancer diagnosis that caused her mother’s death at 56.  
ii This change in technique should be noted, because many of the scholarly articles focused on 
reconstructive surgery experiences specifically target the TRAM Flap as a problematic type of 
procedure. 
iii One does not need to look any further than the high mortality rate of Black breast cancer 
patients, or even new Black mothers, to see the inherent racism in the medical system still 
prevailing in the US. 
iv In fact, breast cancer patients had to lobby extensively for the Women’s Health and Breast 
Cancer Rights Act of 1998 to include a clause that forces health insurance providers to cover 
breast reconstructive procedures with other breast cancer expenses.  
v Amoena Group, for instance, was purchased by Colisée in 2019.  
vi Though medical research from the past 15 years suggests that bisexual and lesbian women are 
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